Cetuximab (anti-EGFR)
Cetuximab, a novel molecular-targeted agent,is an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation. MW：145.781 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2000 |
| Sku # | A2000-1mg*5 |
| Pricing | 1mg*5, $707.00 |